痛风患者的广泛性疼痛超敏反应及相关因素
本研究对97例晶体确诊痛风门诊患者进行横断面调查,用广泛性疼痛问卷(GPQ)筛查广泛性疼痛超敏反应。20例(20.6%,95%CI:13.0,30.0)GPQ评分≥11分提示可能存在广泛性疼痛超敏反应,较低年龄、合并纤维肌痛及社会角色执行困难更多与广泛性疼痛超敏反应独立相关。
要点
- 97例痛风患者中20例(20.6%)GPQ评分≥11分,提示可能存在广泛性疼痛超敏反应。
- 较低年龄、合并纤维肌痛及社会角色执行困难更多与广泛性疼痛超敏反应独立相关。
- 广泛性疼痛超敏反应者使用降尿酸治疗的比例显著更低。
核心结论
- 广泛性疼痛超敏反应在痛风患者中似乎相当常见,尽管痛风比其他炎性关节炎更具间歇性。
- 此类疼痛对常规治疗反应不佳,筛查非炎性疼痛对改善痛风疼痛管理可能重要。
研究设计与样本
- 在晶体确诊痛风门诊患者中进行的横断面调查,使用广泛性疼痛问卷(GPQ)筛查广泛性疼痛超敏反应。
- 共纳入97例患者(84.5%男性;平均(标准差)年龄68.9±11.9岁)。
- 收集自报社会人口学与医学信息,完成多项患者报告结局指标(PROMs)。
- 采用单变量逻辑回归和10折交叉验证的多变量LASSO回归分析探讨与患者特征、临床特征及PROMs的关系。
主要发现
- 97例患者中20例(20.6%,95%CI:13.0,30.0)报告可能的广泛性疼痛超敏反应,定义为GPQ评分≥11分(范围0-28;平均(标准差)GPQ评分6.3±5.3)。
- 较低年龄、合并纤维肌痛及更多经历社会角色执行困难与广泛性疼痛超敏反应独立相关。
- 广泛性疼痛超敏反应患者使用降尿酸治疗的比例显著更低。
关键数值与推荐
- 广泛性疼痛超敏反应定义为GPQ评分≥11分(GPQ范围0-28)。
- 20例(20.6%,95%CI:13.0,30.0)患者GPQ评分≥11分。
- 平均(标准差)GPQ评分为6.3±5.3。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Previous studies have indicated that a sizeable proportion of patients with inflammatory arthritis present with features characteristic of central pain sensitization. However, this has not yet been examined in patients with gout. The objective of this study was to explore the presence of generalized pain hypersensitivity and associated factors in patients with diagnosed gout. METHODS: A cross-sectional survey was performed in outpatients with crystal proven gout using the generalized pain questionnaire (GPQ) to screen for the presence of generalized pain hypersensitivity. Additional self-reported socio-demographic and medical information was collected and several patient-reported outcome measures were completed. Univariable logistic regressions and multivariable LASSO regression analysis with 10-fold cross-validation was used to explore relationships with patient characteristics, clinical features and PROMs. RESULTS: Of the 97 included patients (84.5% male; mean (s.d.) age: 68.9 ± 11.9 years), 20 patients (20.6%, 95% CI: 13.0, 30.0) reported possible generalized pain hypersensitivity defined as a GPQ score ≥11 (range: 0-28; mean (s.d.) GPQ: 6.3 ± 5.3). Lower age, concomitant fibromyalgia and more experienced difficulties in performing their social role were independently associated with generalized pain hypersensitivity. Notably, use of urate lowering therapy was significantly lower in those with generalized pain hypersensitivity. CONCLUSIONS: Generalized pain hypersensitivity appears to be quite common in gout, despite its more intermittent nature compared with other inflammatory arthritides. As this kind of pain does not respond well to regular treatment, screening for non-inflammatory pain may be important for improving pain management in gout.
引用
- Ten Klooster PM, Kraiss JT, Munters R, et al. Generalized pain hypersensitivity and associated factors in gout. Rheumatology (Oxford). 2022. PMID: 34919669. doi:10.1093/rheumatology/keab934
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。